Search





Search





Milestone Pharmaceuticals Inc

MIST

Add to Watchlist

0.792USD

-0.070-8.12%

Market hours 09/24, 14:17（ET）

98.60MMarket Cap

LossP/E TTM

Milestone Pharmaceuticals Inc

0.792

-0.070-8.12%

Financial Summary Income Statement Balance Sheet Cash Flow Statement Earnings Company Valuation Risk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial Summary Income Statement Balance Sheet Cash Flow Statement Earnings Company Valuation Risk Assessment

MIST Cash Flow Statement

You can access the annual and quarterly cash flow statements of Milestone Pharmaceuticals Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-80.76%-22.71M

-15.06%-16.05M

-86.69%-12.78M

-38.90%-9.75M

-107.60%-12.57M

-56.17%-13.95M

30.14%-6.84M

42.29%-7.02M

42.70%-6.05M

35.75%-8.93M

23.84%-9.80M

-5.07%-12.16M

25.00%-10.56M

0.32%-13.90M

-3.92%-12.86M

-23.22%-11.57M

-1487.68%-14.09M

-11.86%-13.95M

-41.34%-12.38M

-28.06%-9.39M

106.13%1.01M

31.02%-12.47M

47.26%-8.76M

11.62%-7.33M

-43.79%-16.56M

-22.71%-18.08M

-127.10%-16.60M

-48.42%-8.30M

-236.69%-11.52M

-211.94%-14.73M

---7.31M

---5.59M

---3.42M

---4.72M

Net income from continuing operations

-120.68%-28.61M

-25.55%-26.07M

-40.82%-17.41M

-26.31%-11.92M

-38.48%-12.97M

-100.51%-20.76M

9.17%-12.36M

37.41%-9.44M

41.64%-9.36M

30.74%-10.35M

-3.29%-13.61M

-3.61%-15.08M

3.63%-16.04M

-6.73%-14.95M

21.96%-13.18M

-2.33%-14.56M

-2262.08%-16.65M

-11.93%-14.01M

-94.83%-16.88M

-18.75%-14.22M

105.93%770.00K

23.43%-12.51M

52.62%-8.67M

6.63%-11.98M

4.97%-12.98M

-56.36%-16.34M

-88.24%-18.29M

-125.09%-12.83M

-280.66%-13.66M

-149.99%-10.45M

---9.72M

---5.70M

---3.59M

---4.18M

Operating gains losses

103.57%57.00K

107.41%56.00K

30.77%34.00K

0.00%25.00K

7.69%28.00K

-3.57%27.00K

0.00%26.00K

4.17%25.00K

8.33%26.00K

55.56%28.00K

73.33%26.00K

-11.11%24.00K

0.00%24.00K

-21.74%18.00K

-34.78%15.00K

12.50%27.00K

4.35%24.00K

0.00%23.00K

-8.00%23.00K

4.35%24.00K

-8.00%23.00K

-4.17%23.00K

4.17%25.00K

155.56%23.00K

1150.00%25.00K

700.00%24.00K

1100.00%24.00K

200.00%9.00K

-33.33%2.00K

50.00%3.00K

--2.00K

--3.00K

--2.00K

Other non-cash items

6.73%1.01M

17.21%1.00M

22.97%985.00K

22.69%968.00K

25.63%951.00K

9.63%854.00K

3.49%801.00K

-3.07%789.00K

-11.36%757.00K

1658.00%779.00K

897.94%774.00K

--814.00K

--854.00K

---50.00K

---97.00K

----

Change in working capital

88.61%-215.00K

-0.79%4.54M

-98.04%63.00K

-133.17%-69.00K

-267.29%-1.89M

609.12%4.58M

182.86%3.22M

126.36%208.00K

-46.51%1.13M

26.01%-899.00K

160.31%1.14M

-236.98%-789.00K

1547.66%2.11M

41.56%-1.22M

-175.21%-1.89M

-79.32%576.00K

107.57%128.00K

-54.34%-2.08M

262.29%2.51M

-15.07%2.79M

64.78%-1.69M

50.86%-1.35M

-218.20%-1.55M

-21.42%3.28M

-357.73%-4.80M

39.02%-2.74M

-36.47%1.31M

19771.43%4.17M

2090.59%1.86M

-571.90%-4.50M

--2.06M

--21.00K

--85.00K

---669.00K

-Change in receivables

558.23%1.04M

-749.13%-1.49M

-483.09%-2.00M

43.48%495.00K

158.74%158.00K

-86.68%230.00K

80.52%-343.00K

166.99%345.00K

-150.47%-269.00K

292.96%1.73M

-202.06%-1.76M

-402.94%-515.00K

472.73%533.00K

-414.37%-895.00K

-389.92%-583.00K

-78.23%170.00K

-175.00%-143.00K

-20.00%-174.00K

-308.77%-119.00K

597.45%781.00K

-154.74%-52.00K

-35.51%-145.00K

-46.73%57.00K

39.15%-157.00K

157.23%95.00K

-172.30%-107.00K

133.44%107.00K

-3325.00%-258.00K

-297.62%-166.00K

57.45%148.00K

---320.00K

--8.00K

--84.00K

--94.00K

-Change in inventory

---2.90M

---1.18M

---648.00K

----

-Change in prepaid expenses

-89.12%175.00K

215.31%595.00K

12.15%766.00K

-125.80%-1.83M

147.77%1.61M

-163.24%-516.00K

-81.95%683.00K

48.11%-810.00K

1280.85%649.00K

46.24%816.00K

499.47%3.78M

2.01%-1.56M

-92.21%47.00K

141.56%558.00K

-156.74%-947.00K

-207.71%-1.59M

152.21%603.00K

126.74%231.00K

186.75%1.67M

-43.72%1.48M

74.71%-1.16M

-408.57%-864.00K

-215.07%-1.92M

73.47%2.63M

-1080.04%-4.57M

106.83%280.00K

2254.93%1.67M

247.66%1.52M

54.82%466.00K

-536.65%-4.10M

--71.00K

---1.03M

--301.00K

---644.00K

-Change in payables and accrued expense

----

-32.41%1.95M

88.31%1.27M

-585.77%-3.65M

241.78%4.87M

418.47%2.88M

-47.88%676.00K

-51.64%752.00K

-276.32%-3.43M

-131.20%-904.00K

-33.42%1.30M

578.46%1.56M

57.36%-912.00K

-140.81%-391.00K

271.76%1.95M

34.34%-325.00K

-511.14%-2.14M

258.80%958.00K

-35.55%524.00K

-47.32%-495.00K

87.62%-350.00K

155.51%267.00K

-72.15%813.00K

-120.33%-336.00K

-395.10%-2.83M

-121.36%-481.00K

180.94%2.92M

690.36%1.65M

-322.96%-571.00K

--2.25M

--1.04M

---280.00K

---135.00K

-Change in other current liabilities

--618.00K

--416.00K

----

---33.00K

--33.00K

----

Cash from non-recurring investing activities

Cash from operating activities

-80.76%-22.71M

-15.06%-16.05M

-86.69%-12.78M

-38.90%-9.75M

-107.60%-12.57M

-56.17%-13.95M

30.14%-6.84M

42.29%-7.02M

42.70%-6.05M

35.75%-8.93M

23.84%-9.80M

-5.07%-12.16M

25.00%-10.56M

0.32%-13.90M

-3.92%-12.86M

-23.22%-11.57M

-1487.68%-14.09M

-11.86%-13.95M

-41.34%-12.38M

-28.06%-9.39M

106.13%1.01M

31.02%-12.47M

47.26%-8.76M

11.62%-7.33M

-43.79%-16.56M

-22.71%-18.08M

-127.10%-16.60M

-48.42%-8.30M

-236.69%-11.52M

-211.94%-14.73M

---7.31M

---5.59M

---3.42M

---4.72M

Investing cash flow

Net cash from continuing investing activities

136.36%26.00K

650.00%45.00K

1186.36%283.00K

-50.00%2.00K

57.14%11.00K

--6.00K

-29.03%22.00K

-77.78%4.00K

-77.42%7.00K

----

-71.82%31.00K

-82.52%18.00K

-47.46%31.00K

--32.00K

--110.00K

--103.00K

--59.00K

----

--101.00K

--294.00K

--18.00K

-100.00%0.00

--0.00

--5.00K

Capital expenditures

136.36%26.00K

650.00%45.00K

1186.36%283.00K

-50.00%2.00K

57.14%11.00K

--6.00K

-29.03%22.00K

-77.78%4.00K

-77.42%7.00K

----

-71.82%31.00K

-82.52%18.00K

-47.46%31.00K

--32.00K

--110.00K

--103.00K

--59.00K

----

--101.00K

--294.00K

--18.00K

-100.00%0.00

--0.00

--5.00K

Net cash flow from disposal of fixed assets

136.36%26.00K

650.00%45.00K

1186.36%283.00K

-50.00%2.00K

57.14%11.00K

--6.00K

-29.03%22.00K

-77.78%4.00K

-77.42%7.00K

----

-71.82%31.00K

-82.52%18.00K

-47.46%31.00K

--32.00K

--110.00K

--103.00K

--59.00K

----

--101.00K

--294.00K

--18.00K

-100.00%0.00

--0.00

--5.00K

Net cash flow from business transactions

140.00%18.00K

-9020.30%-79.98M

-236.56%-47.01M

-17.55%-34.98M

99.74%-45.00K

98.33%-877.00K

---13.97M

---29.76M

---17.31M

---52.51M

----

---22.91M

---39.95M

---15.00M

---8.00M

----

---30.00M

---28.00M

8.57%-32.00M

----

-100.00%0.00

100.00%0.00

---35.00M

----

--5.97M

---9.00M

----

Net cash flow from investment products

1020.00%112.00M

-100.00%0.00

50.04%50.00M

-100.00%0.00

-62.69%10.00M

35.16%34.47M

143.12%33.33M

434.39%36.24M

195.71%26.80M

-15.00%25.50M

128.45%13.71M

-147.13%-10.84M

---28.00M

--30.00M

-60.00%6.00M

0.00%23.00M

-100.00%0.00

-6.25%15.00M

475.00%23.00M

--20.00M

--12.00M

-46.67%16.00M

-20.00%4.00M

----

895.36%30.00M

408.65%5.00M

-99.64%29.00K

-100.00%0.00

--3.01M

--983.00K

--8.03M

--7.00M

Net cash flow from other investing activities

----

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

1026.23%111.99M

-338.31%-80.03M

-86.02%2.70M

-639.79%-34.98M

4.87%9.94M

224.32%33.58M

41.37%19.33M

159.69%6.48M

133.83%9.48M

-190.14%-27.01M

180.38%13.68M

36.32%-10.86M

-86.14%-28.03M

474.60%29.97M

-213.43%-17.02M

-174.13%-17.05M

-175.29%-15.06M

-166.67%-8.00M

207.14%15.00M

195.83%23.00M

162.50%20.00M

--12.00M

-146.82%-14.00M

-609.99%-24.00M

8.54%-32.00M

----

232.77%29.90M

158.70%4.71M

-535.51%-34.99M

-100.00%0.00

--8.98M

---8.02M

--8.03M

--7.00M

Financing cash flow

Cash flow from continuous financing activities

25269.44%9.13M

67295.71%94.35M

151704.17%36.43M

66005.41%48.92M

112.08%36.00K

-99.57%140.00K

2300.00%24.00K

-75.74%74.00K

89.23%-298.00K

-35.69%32.32M

-99.56%1.00K

-88.59%305.00K

-2076.43%-2.77M

102457.14%50.25M

146.74%227.00K

11033.33%2.67M

-97.15%140.00K

157.89%49.00K

-99.81%92.00K

-99.90%24.00K

2760.47%4.92M

-75.32%19.00K

229219.05%48.16M

3495.08%24.82M

-99.80%172.00K

208.00%77.00K

-99.97%21.00K

---731.00K

1229785.71%86.09M

-16.67%25.00K

--80.08M

--0.00

--7.00K

--30.00K

Net cash flow from debt Issuance/repayment

--0.00

--75.00M

----

-100.00%0.00

--0.00

--50.00M

----

Net cash flow from common stock issuance/repurchase

--0.00

7810.00%11.07M

--37.37M

31390.54%23.30M

100.00%0.00

-99.49%140.00K

--0.00

-72.08%74.00K

---280.00K

21337.98%27.66M

100.00%0.00

-89.98%265.00K

----

--129.00K

---14.00K

--2.64M

----

1245750.00%24.92M

----

--2.00K

---731.00K

--86.09M

----

Net cash flow from preferred stock issuance/repurchase

----

-100.00%0.00

----

--80.00M

----

Proceeds from stock option exercised by employees

-22.22%28.00K

----

1091.67%286.00K

--122.00K

24.14%36.00K

----

2300.00%24.00K

-100.00%0.00

20.83%29.00K

----

-99.51%1.00K

42.86%40.00K

-82.86%24.00K

153.06%124.00K

160.26%203.00K

16.67%28.00K

--140.00K

157.89%49.00K

2500.00%78.00K

-50.00%24.00K

-100.00%0.00

-75.32%19.00K

-84.21%3.00K

--48.00K

--172.00K

208.00%77.00K

-95.52%19.00K

--0.00

-100.00%0.00

-16.67%25.00K

--424.00K

--0.00

--7.00K

--30.00K

Proceeds from issuance of warrants

--9.12M

--8.29M

---1.22M

--22.92M

----

171.43%38.00K

----

-99.94%14.00K

-100.00%0.00

--4.92M

----

--23.24M

--24.77M

----

Net cash flow from other financing activities

---11.00K

--0.00

--2.57M

----

-100.00%0.00

--0.00

98.32%-47.00K

--4.66M

--0.00

---2.79M

----

---346.00K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

25269.44%9.13M

67295.71%94.35M

151704.17%36.43M

66005.41%48.92M

112.08%36.00K

-99.57%140.00K

2300.00%24.00K

-75.74%74.00K

89.23%-298.00K

-35.69%32.32M

-99.56%1.00K

-88.59%305.00K

-2076.43%-2.77M

102457.14%50.25M

146.74%227.00K

11033.33%2.67M

-97.15%140.00K

157.89%49.00K

-99.81%92.00K

-99.90%24.00K

2760.47%4.92M

-75.32%19.00K

229219.05%48.16M

3495.08%24.82M

-99.80%172.00K

208.00%77.00K

-99.97%21.00K

---731.00K

1229785.71%86.09M

-16.67%25.00K

--80.08M

--0.00

--7.00K

--30.00K

Net cash flow

Beginning cash balance

58.18%71.32M

188.56%73.05M

264.76%46.69M

220.46%42.50M

345.02%45.09M

83.97%25.31M

29.56%12.80M

-59.31%13.26M

-86.30%10.13M

80.20%13.76M

-73.50%9.88M

-48.46%32.59M

-19.83%73.95M

-93.31%7.64M

-66.54%37.29M

-35.34%63.24M

28.36%92.24M

57.85%114.14M

137.53%111.43M

83.05%97.79M

-29.42%71.86M

-39.65%72.31M

-55.95%46.91M

-51.79%53.43M

42.92%101.82M

39.41%119.82M

2438.76%106.50M

522.50%110.82M

440.39%71.24M

689.95%85.95M

--4.20M

--17.80M

--13.18M

--10.88M

Current period cash flow changes

3905.53%98.41M

-108.75%-1.73M

110.64%26.36M

1004.10%4.19M

-182.59%-2.59M

644.81%19.77M

222.47%12.52M

97.96%-463.00K

107.57%3.13M

-105.47%-3.63M

113.09%3.88M

12.48%-22.71M

-42.61%-41.36M

402.82%66.32M

-1192.08%-29.65M

-290.37%-25.95M

-211.83%-29.00M

-4755.88%-21.90M

-89.31%2.71M

309.21%13.63M

153.60%25.93M

97.49%-451.00K

90.73%25.40M

-50.73%-6.52M

-222.24%-48.39M

-22.40%-18.00M

-83.71%13.32M

68.23%-4.32M

756.82%39.59M

-738.65%-14.71M

--81.75M

---13.61M

--4.62M

--2.30M

Ending cash balance

299.37%169.73M

58.18%71.32M

188.56%73.05M

264.76%46.69M

220.46%42.50M

345.02%45.09M

83.97%25.31M

29.56%12.80M

-59.31%13.26M

-86.30%10.13M

80.20%13.76M

-73.50%9.88M

-48.46%32.59M

-19.83%73.95M

-93.31%7.64M

-66.54%37.29M

-35.34%63.24M

28.36%92.24M

57.85%114.14M

137.53%111.43M

83.05%97.79M

-29.42%71.86M

-39.65%72.31M

-55.95%46.91M

-51.79%53.43M

42.92%101.82M

39.41%119.82M

2438.76%106.50M

522.50%110.82M

440.39%71.24M

--85.95M

--4.20M

--17.80M

--13.18M

Free cash flow

-80.81%-22.74M

-15.33%-16.10M

-90.21%-13.06M

-38.85%-9.75M

-107.54%-12.58M

-56.23%-13.96M

30.14%-6.87M

42.34%-7.02M

42.80%-6.06M

35.89%-8.93M

24.24%-9.83M

-4.30%-12.18M

25.09%-10.60M

0.09%-13.94M

-4.81%-12.97M

-24.32%-11.68M

-1493.50%-14.14M

-11.86%-13.95M

-41.34%-12.38M

-28.06%-9.39M

106.13%1.01M

---12.47M

47.58%-8.76M

14.64%-7.33M

-43.57%-16.56M

----

-128.48%-16.70M

-53.68%-8.59M

-237.21%-11.54M

-211.61%-14.73M

---7.31M

---5.59M

---3.42M

---4.73M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Milestone Pharmaceuticals Inc Generate?



Milestone Pharmaceuticals Inc generated -49.04M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Milestone Pharmaceuticals Inc's Operating Cash Flow Change Year Over Year?



Milestone Pharmaceuticals Inc's operating cash flow increased by -70.00% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Milestone Pharmaceuticals Inc Spend on Capital Expenditures?



Milestone Pharmaceuticals Inc spent 302.00K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Milestone Pharmaceuticals Inc's Financing Cash Flow Changed?



Milestone Pharmaceuticals Inc used 85.53M in financing activities in the latest quarter.

What is free cash flow and why does it matter for MIST?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Milestone Pharmaceuticals Inc’s free cash flow in the latest quarter?



Free cash flow was -49.34M reflecting a -70.85% change from the previous year.